european medicines agency news

EU regulator backs use of Novo's Wegovy for obesity-related heart condition

The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday. This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the medicine has multiple health benefits.

YAHOO!Finance · 19h

European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide 2.4 mg) label. The label update incorporates data showing that Wegovy,

The Wall Street Journal on MSN · 1d

Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.

Business Insider · 1d

Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a

DPA International on MSN18h

EU extends authorization of the mpox vaccine to adolescents

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

Medscape16h

Two New Drugs Approved for Age-Related Macular Degeneration

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

El País in English3h

Kerstin Noëlle Vokinger: ‘New cancer therapies are being approved for patient groups not included in clinical trials’

Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the ...

17h

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

19h

Merck Gets European Panel Backing for Keytruda in Two Gynecologic Cancers

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

23hon MSN

European shares slip but set for weekly gains; Mercedes drops

By Shubham Batra (Reuters) -European shares slipped on Friday after a rally in the previous session spurred by the U.S.

17h

Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a ...

devdiscourse10h

Health Headlines: Regulatory Approvals and Legal Battles

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

Medscape14h

Hympavzi Approved in Europe for Severe Hemophilia A and B

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Novartis Breast Cancer Drug Found To Cut Disease Recurrence

Novartis said its Kisqali breast cancer drug produced longer success for those with certain forms of the disease.

Investor's Business Daily on MSN11h

Apellis Stock Hammered After Eye Drug Gets A Third European Rejection

European regulators rejected Apellis Pharmaceuticals' embattled eye drug, Syfovre, and Apellis stock tumbled to a month-low.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics